Initiator Pharma A/S (“Initiator Pharma” or “the Company”) rights issue has now been registered with the Danish Companies Registration Office. The Company hereby announces that the last day of trading in paid subscribed shares (Sw. BTA) will be on 21 July 2022 and stop day will be on 25 July 2022.
In June 2022, Initiator Pharma conducted a rights issue, which provided the Company with approximately SEK 41 million before transaction related costs. The rights issue has now been registered with the Danish Companies Registration Office and the last day of trading in BTA will be on 21 July 2022 and stop day will be on 25 July 2022. The shares are estimated to be delivered to each shareholder’s account on 27 July 2022.
Through the rights issue, Initiator Pharma’s share capital have increased by DKK 573,659.73, from DKK 4,924,338.405 to DKK 5,497,998.14. The total number of shares have increased by 5,463,426, from 46,898,461 to 52,361,887.